XCMR Showcases Next-Generation PPE at the ATS 2024 Respiratory Innovation Summit

XCMR presented its innovative respiratory protection solutions at the 2024 Respiratory Innovation Summit (RIS).

The company highlighted the limitations of traditional PPE and the need for advancements in efficacy, performance, and comfort.

XCMR's proprietary UV-C microreactor technology offers a promising solution for next-generation PPE.

The Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society (ATS), serves as a crucial platform for fostering innovation in respiratory health. The ATS, the nation’s leading medical society dedicated to improving global respiratory health, organizes this annual summit to connect key stakeholders and accelerate the development of novel treatments for respiratory diseases. The 2024 RIS focused on uniting innovators, investors, clinicians, and advocacy groups to drive advancements in pulmonary, critical care, and sleep medicine.

At this year’s RIS, XCMR showcased its groundbreaking approach to respiratory protection, emphasizing the need to modernize outdated PPE. The company highlighted the limitations of traditional PPE, which often relies on filtration and can be uncomfortable, cumbersome, and single-use.

XCMR presented its proprietary UV-C microreactor technology as a solution for next-generation PPE. This technology offers several advantages over traditional methods, including:

Enhanced efficacy: UV-C light effectively inactivates pathogens, providing a higher level of protection than filtration alone.
Improved performance: The technology allows for continuous disinfection without compromising breathability or comfort.
Increased comfort: The lightweight and ergonomic design reduces user encumbrance and improves the overall user experience.
Sustainability: UV-C reactors are reusable, reducing waste and environmental impact compared to disposable PPE.

XCMR’s presentation also highlighted the potential of its technology to integrate with EMITR™ (Electromagnetic Energy for Infection Transmission Resiliency), the company’s IoT cloud platform that enables AI, data, and sensor fusion for enhanced infection transmission resiliency.

XCMR’s participation in the 2024 Respiratory Innovation Summit showcased the company’s commitment to revolutionizing respiratory protection. By addressing the limitations of traditional PPE and offering innovative solutions, XCMR is poised to make a significant impact on the future of respiratory health.